Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06261489 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cannabis (THC vs. CBD) in Multiple Sclerosis

Name: Cannabis (THC vs. CBD) in Multiple Sclerosis — clinical trial record (NCT06261489)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorUniversity of Calgary

Started2025-12-05

View on ClinicalTrials.gov ↗

The goal of this clinical trial is to examine the effect of Cannabis components, THC and CBD, on cognition and bladder symptoms in people with Multiple Sclerosis (MS). Participants will complete questionnaires and cognitive tests. They will be randomly assigned to receive either CBD or THC oil and will take the study drug for 15 weeks.

Amendment history 3 changes detected by DataLookout

2026-09-10

Enrollment reopened

2026-09-10

Primary completion pushed: 2026-09 → 2027-09-30

2026-09-10

Completion pushed: 2026-09 → 2027-09-30

Trial Details

NCT Number	NCT06261489
Lead Sponsor	University of Calgary Collaborators: Multiple Sclerosis Society of Canada
Conditions	Multiple Sclerosis
Enrollment	30 participants
Start Date	2025-12-05
Primary Completion	2027-09-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-15